An official website of the United States government
Home
A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Category | Primary Site | Code? |
|---|---|---|---|
| Betamethasone Dipropionate | Hormones and hormonal mechanisms | See Remarks | |
| Betamethasone Sodium Phosphate | Hormones and hormonal mechanisms | See Remarks | |
| Betamethasone Valerate | Hormones and hormonal mechanisms | See Remarks | |
| Bethasone Benzoate | Hormones and hormonal mechanisms | adult leukemia and lymphoma, Childhood leukemia | Yes |
| Bevacizumab | Biologic therapy (BRM, immunotherapy) | Breast- see remarks, Fallopian tube, Ovary, Peritoneum, Colon and rectum, Kidney, Lung-NSCLC, Liver, Brain, Cervix | Yes |
| Bexarotene | Chemotherapy | Breast, colorectal, Cutaneous T-cell lymphoma, head & neck, kidney, lung | Yes |
| Binimetinib | Chemotherapy | Yes | |
| Bisantrene Hydrochloride | Chemotherapy | Leukemia | Yes |
| Bizengri | Biologic therapy (BRM, immunotherapy) | Lung, pancreas | Yes |
| Bleomycin | Chemotherapy | Squamous cell cancers | Yes |
| Blinatumomab | Biologic therapy (BRM, immunotherapy) | Yes | |
| Borocaptate Sodium B 10 | Ancillary Agent | No | |
| Bortezomib | Chemotherapy | Breast, Mantle cell lymphoma, colorectal, leukemia, lung cancer, multiple myeloma | Yes |
| Bosutinib | Chemotherapy | CML | Yes |
| Brentuximab vedotin | Biologic therapy (BRM, immunotherapy) | Anaplastic large cell lymphoma (ALCL), Hodgkin Lymphoma | Yes |
| Brequinar Sodium | Ancillary Agent | No | |
| Brigatinib | Chemotherapy | Lung | Yes |
| Bromocriptine mesylate | Hormones and hormonal mechanisms | pituitary gland | See Remarks |
| Bromodeoxyuridine | Ancillary Agent | No | |
| Bropirimine | Biologic therapy (BRM, immunotherapy) | Bladder | Yes |
| Broxuridine | Ancillary Agent | No | |
| Bruceantin | Chemotherapy | Yes | |
| Bryostatin | Chemotherapy | Breast, cervical, esophageal, gastric, head & neck, kidney, leukemia, metastatic solid tumors, ovarian, prostate cancer | Yes |
| Bryostatin 1 | Chemotherapy | Yes | |
| Buserelin Acetate | Hormones and hormonal mechanisms | Prostate cancer | Yes |
| Busulfan | Chemotherapy | CML | Yes |
| CAR-T | Biologic therapy (BRM, immunotherapy) | Yes | |
| CBT-1 | Ancillary Agent | No | |
| CHIR-258 | Chemotherapy | Multiple myeloma | Yes |
| CSF-2 | Ancillary Agent | AIDS, Opportunistic infection | No |
| CSF-Macrophage | Ancillary Agent | No | |
| CT-2106 | Chemotherapy | Colon cancer | Yes |
| CTCE-9908 | Chemotherapy | glioblastoma, Osteosarcoma | Yes |
| CTL019 | Biologic therapy (BRM, immunotherapy) | Yes | |
| CV787 | Chemotherapy | Prostate cancer | Yes |
| CX-3543 | Chemotherapy | Yes | |
| CX-4945 | Chemotherapy | Breast, Colorectal, H&N, Kidney, Lung, Mult Myeloma, Prostate | Yes |
| CX43 | Ancillary Agent | Prostate, breast cancer | No |
| CYNK-001 | Biologic therapy (BRM, immunotherapy) | Brain | Yes |
| Cabazitaxel | Chemotherapy | Prostate | Yes |
| Cabergoline | Hormones and hormonal mechanisms | Pituitary (prolactinoma) | Yes |
| Cabozantinib | Chemotherapy | Thyroid, Kidney | Yes |
| Cactinomycin | Chemotherapy | Yes | |
| Caffeine | Ancillary Agent | Pancreatic cancer | No |
| Calcitonin | Ancillary Agent | No | |
| Calcium Carbonate | Ancillary Agent | No | |
| Calcium Gluconate | Ancillary Agent | No | |
| Calusterone | Hormones and hormonal mechanisms | Yes | |
| Camcevi | Hormones and hormonal mechanisms | Prostate | Yes |
| Camptothecin | Chemotherapy | Yes | |
| Camptothecin Glycoconjugate | Chemotherapy | Other cancer | Yes |
| Cancer Vaccine | Biologic therapy (BRM, immunotherapy) | Bladder, breast, kidney, ovarian, skin cancer | Yes |
| Canvaxin | Biologic therapy (BRM, immunotherapy) | Colorectal, skin cancer | Yes |
| Capecitabine | Chemotherapy | Breast cancer, Colorectal cancer, Gastric, esophageal and gastroesophageal junction cancer, Pancreatic cancer | Yes |
| Capivasertib | Chemotherapy | Breast | Yes |
| Capreomycin Sulfate | AIDS drug | No | |
| Caracemide | Chemotherapy | Renal cell cancer | Yes |
| Carbenicillin | Ancillary Agent | No | |
| Carbenoxolone Sodium | Ancillary Agent | No | |
| Carbetimer | Chemotherapy | Yes | |
| Carboplatin | Chemotherapy | All cancers | Yes |
| Carboxyamidotriazole | Chemotherapy | Kidney, lung, ovarian cancer | Yes |
| Carfilzomib | Chemotherapy | Multiple myeloma | Yes |
| Carmustine | Chemotherapy | Brain, Hodgkin Lymphoma, Kidney cancer, Multiple myeloma, Non-Hodgkin lymphoma | Yes |
| Carubicin (HCl) | Chemotherapy | Leukemia, lymphoma, solid tumors | Yes |
| Casodex | Hormones and hormonal mechanisms | Prostate | Yes |
| Casopitant | Ancillary Agent | No | |
| Castanospermine | AIDS drug | No | |
| Catumaxomab | Chemotherapy | Ovary | Yes |
| CeaVac Anti-idiotype antibody | Biologic therapy (BRM, immunotherapy) | Colon cancer | Yes |
| Cediranib | Chemotherapy | glioblastoma, NSCLC, renal cell | Yes |
| Cefoperazone | Ancillary Agent | No | |
| Ceftriaxone Sodium | Ancillary Agent | No | |
| Celebrex | Ancillary Agent | Bladder, breast cancer | No |
| Celengitide | Chemotherapy | Brain cancer | Yes |
| Cemiplimab | Biologic therapy (BRM, immunotherapy) | Lung, Skin | Yes |
| Cephalosporin | Ancillary Agent | No | |
| Ceplene | Biologic therapy (BRM, immunotherapy) | Kidney cancer, leukemia | Yes |
| Cereport | Ancillary Agent | Brain cancer | No |
| Cetuximab | Biologic therapy (BRM, immunotherapy) | Breast, colorectal, head & neck, lung, ovarian, pancreatic cancer | Yes |
| Chimeric MAb14.18 | Biologic therapy (BRM, immunotherapy) | melanoma, Neuroblastoma | Yes |
| Chlorambucil | Chemotherapy | Yes | |
| Chlorhexidine Gluconate | Ancillary Agent | No | |
| Chlormadinone Acetate | Hormones and hormonal mechanisms | Yes | |
| Chlornaphazine | Ancillary Agent | No | |
| Chloroquinoxaline Sulfonamide | Chemotherapy | Lung cancer | Yes |
| Chlorotrianisene | Hormones and hormonal mechanisms | Prostate cancer | Yes |
| Chlorozotocin | Chemotherapy | Pancreatic cancer | Yes |
| Chlorpromazine | Ancillary Agent | No | |
| Chlorsulfaquinoxaline | Chemotherapy | Yes | |
| Cholecalciferol | Ancillary Agent | No | |
| Chromic Phosphate P32 | Radiation | CLL and chronic myeloid leukemia, Ovarian and prostatic carcinoma, palliative in bone metastases | Yes |
| Chromomycin | Chemotherapy | Yes | |
| Cidofovir | AIDS drug | No | |
| Cilastatin Sodium | Chemotherapy | Yes | |
| Cilengitide | Chemotherapy | Other cancer | Yes |
| Cimetidine | Ancillary Agent | Other | No |
| Cingestol | Hormones and hormonal mechanisms | Yes | |
| Ciprofloxacin Hydrochloride | Ancillary Agent | No | |
| Cirolemycin | Chemotherapy | Yes |
